FDA Approvals

Date Posted
Article Title
1/26/2015
New Bacterial Meningitis Vaccine Approved

Bexsero prevents deadly infection of spinal cord lining

1/21/2015
New Psoriasis Drug Approved

Cosentyx hinders protein that spurs skin inflammation

1/14/2015
Stimulation Device Approved to Treat Obesity

Targets nerve between brain and stomach that regulates hunger

1/9/2015
Blood-Thinning Drug Savaysa Approved

Designed to treat dangerous clots and prevent stroke

12/24/2014
Saxenda Approved for Weight Loss

Injected medication is for people who are statistically obese

12/22/2014
Opdivo Approved for Advanced Melanoma

Drug helps harness immune system to attack the cancer

12/22/2014
Antiviral Combination Approved for Hepatitis C

Some 3.2 million Americans thought infected

12/22/2014
Rapivab Approved to Help Treat Flu

Intravenous drug inhibits viral enzyme

12/22/2014
Combination Antibiotic Zerbaxa Approved

Sanctioned for complicated abdominal, urinary tract infections

12/19/2014
Lynparza Approved for Advanced Ovarian Cancer

Associated with genetic defect

12/19/2014
System Approved to Remove Germs From Blood Platelets

Lowers chances of infected donation

12/18/2014
Xtoro Approved for Swimmer's Ear

Infection's symptoms include pain, swelling and redness

12/17/2014
New System Targets Germs in Donated Blood Plasma

Reduces risk of infected donation

12/16/2014
First Newborn Screening Test Approved for Rare Immune Disorder

Blood test can help identify Severe Combined Immunodeficiency

12/15/2014
New Test Estimates Risk of Heart Disease

Agency says best results obtained for black women

12/12/2014
Cyramza Approval Expanded to Include Non-Small Lung Cancer

Drug blocks blood supply that fuels tumors

12/11/2014
Screening Test Approved for Viruses That Cause Blood Cancer

Screen looks for viruses tied to a number of blood cancers or abnormalities

12/10/2014
Gardasil Approved for Additional Types of HPV

Virus can lead to cervical cancer

12/4/2014
Jakafi Approved for Chronic Bone Marrow Disease

First drug sanctioned in U.S. for polycythemia vera

12/3/2014
Blincyto Approved for Rare Leukemia

Drug sanctioned for rapidly-growing form of bone marrow cancer